Palliative Radiation Therapy for Metastatic, Persistent, or Recurrent Epithelial Ovarian Cancer: Efficacy in the Era of Modern Technology and Targeted Agents

PURPOSE: Metastatic, persistent, or recurrent epithelial ovarian cancer (MPR-EOC) remains a significant threat to patient mortality despite advances in novel targeted agents. Radiation therapy (RT) is often used as a palliative option. We report outcomes of a large series of MPR-EOC patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Butala, Anish A., Patel, Roshal R., Manjunath, Shwetha, Latif, Nawar A., Haggerty, Ashley F., Jones, Joshua A., Taunk, Neil K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897761/
https://www.ncbi.nlm.nih.gov/pubmed/33665491
http://dx.doi.org/10.1016/j.adro.2020.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897761/
https://www.ncbi.nlm.nih.gov/pubmed/33665491
http://dx.doi.org/10.1016/j.adro.2020.11.009

Ejemplares similares